|
Cases
Here are some cases involving the use of cetyl
myristoleate from the author's practice.
Leona - She is a 64 year old mother of five
who has been developing degenerative changes in her fingers over
the last 15 years. She plays the piano frequently and had to
reduce the amount of playing time as a result of the arthritis
pain in her fingers. ANA titers have been mildly elevated over
the years and rheumatoid disease has been diagnosed in several
of her ancestors and one sibling. Leona's other medical problems
are mild hypertension and chronic sacro-lumbar pain which appears
to be attributable both to sciatic damage sustained in a water
skiing accident 24 years ago and Shunerman's disease as teenager.
Demonstrating both rheumatoid and osteoarthritis changes in her
fingers, she has a mild nodular deformity at the terminal joints
of the 3rd and 4th fingers on the left hand and fusiform swelling
in the medial and distal joints of most of her fingers. Her thumbs
were intermittently painful and swollen. She first took cetyl
myristoleate in mid-January, 1997. There is now increased range
of motion in all of the finger joints and visible reduction of
the rheumatoid-like swelling. The nodular deformities have not
changed noticeably. Her back problems demonstrated no improvement.
Her sedimentation rate has run from 15 to 35, and is currently
16, with her ANA <1:360. Leona is now able to play the piano
all she wants to without pain or swelling of her fingers.
Joyce - She is a 42 year old mother of three
and a court reporter in good general health, suffering only from
moderate hayfever in the spring. Recently Joyce developed a generalized
stiffness and soreness in her fingers, which was worse on her
right hand. The condition became so bad over a couple of weeks
that she began making numerous mistakes in her court reporting
and her speed was significantly reduced. She was diagnosed with
tenosynovitis. Joyce shows no deformities of her hands associated
with arthritis. She began a course of cetyl myristoleate during
the last week of February and finished the last week of March,
1997. She reports complete restoration of her dexterity with
return of her normal accuracy and speed, along with elimination
of the associated pain.
Bob - He is a 67 year-old retired politician
who suffered lumbar and pelvic fractures in WWII when his jeep
struck a land mine. Over the years, these injuries produced increasing
pain, which seriously affected routine daily activities like
getting out of bed in the morning and his ability to play golf.
X-rays demonstrate degenerative arthritic changes in the lumbar
articulations and the right sacroiliac joint. At 6 feet tall
and 185 pounds, he is otherwise in good health. Bob has been
using anti-inflammatory drugs for over 20 years, including Voltaren,
ibuprofen, Tylenol, and aspirin. He took a one-half course of
7.6 grams of cetyl myristoleate in September, 1996. He experienced
moderately severe inflammation (breakthrough pain) on day two
which lasted for three days. On the 4th day, the pain began to
subside and was completely gone by the 5th day. He has been virtually
pain-free since and is very happy with the increased comfort
with which he can begin each day. He can now comfortably walk
the golf course whereas before he was limited to a golf cart.
In February, 1997, he perceived a slight return of his low back
pain and decided to take another one-half course. He experienced
no breakthrough pain this time and is currently pain-free. He
has not taken any other medication for his back pain since taking
cetyl myristoleate initially.
Majesticia - She is an 85 year-old lady who
still works part-time at the family-owned business and cares
for her husband who has cancer. Majesticia was diagnosed ten
years ago with diabetes, and elevated triglycerides and cholesterol.
Overweight all her life, she is now stable at 265 pounds. She
suffers from long-standing osteoarthritis in her knees and ankles,
for which she was placed on cetyl myristoleate. No other agents
have been used by her for arthritis except for non-steroidal
anti-inflammatory drugs, both OTC and prescription. After about
7.6 grams of cetyl myristoleate, she was able to walk without
limping or experiencing significant pain. About three months
following the initial course, some pain returned, but she has
retained what she estimates to be 50% improvement. She also has
gallstones and a recurrent problem with gout, both of which have
been symptomless since her cetyl myristoleate course. She evidently
did not receive enough cetyl myristoleate for her body weight
and will be given another course of 13.25 grams.
Rose - Rose is a 46 year old mother of four
who works as a legal secretary. She was diagnosed five years
ago as having an atypical form of multiple sclerosis. She had
MRI exams of the skull and spinal cord, which demonstrated several
areas of non-specific degenerative changes in the brain with
several "bright spots" in the cervical spinal cord.
She had periodic visual aberrations as well as constant fatigue
and fibromyalgia-like pains focused in her trapezius (bilaterally),
and in her upper arms and legs below the knees. She also complained
of burning sensations in her hands and feet. All of the symptoms
worsened with elevated stress. There was no sign of pernicious
anemia or diabetes. She was receiving chiropractic therapy. Joyce
was started on numerous naturopathic therapies in March, 1996
without significant benefit over an eight month period. In November,
1996, she started on cetyl myristoleate and indicated that she
felt more fatigued for the first three days but that the pain
in her upper back and extremities was completely gone. She further
reported that the tingling/burning sensation in her feet and
hands was also gone. Rose felt this was the most striking aspect
of the treatment as those areas were the ones most constantly
affected. This improvement lasted until she had to travel out
of state to tend to her mother who was diagnosed with a rapidly
advancing malignancy. Over the next three weeks, her symptoms
began to reappear. After the death of her mother, she returned
home in as bad shape as before first taking cetyl myristoleate.
She decided that she wanted to take another half course of cetyl
myristoleate, which completely duplicated the relief from the
initial dosage with the exception that she feels slightly less
relief from her tendencies to fatigue than she did after the
first course. Rose will be taking another half course to see
if she can improve her stamina.
J.P. - He is a 60 year old male who has been
a farmer his entire life. Diagnosed with rheumatoid arthritis
15 years ago, he has been on various pharmacologic protocols
during that time. The most recent includes Plaquenil, methotrexate,
and prednisone, with daily non-steroidal anti-inflammatory drug
dosing. J.P. has fusiform swelling involving most of the joints
of his fingers and moderate ulnar deviation of both hands. He
suffered severe pain most of the time which limited the labor
he could perform. He began cetyl myristoleate during the last
week of February, 1997, at which time he terminated his methotrexate
and Plaquenil (not recommended except in consultation with a
qualified physician). He has also reduced his prednisone from
15 milligrams per day to 5 mg, but he still maintains his NSAID
dosing on a daily basis. J.P. experienced a mild increase in
pain during the first four days of taking cetyl myristoleate,
but since then he has been pain free and the swelling in his
hands is reducing. J.P. will be monitored over the next month
to determine his stability, with checking of his serum parameters
by an MD. If he continues to remain symptom-free, his steroid
and NSAID therapies will be terminated. J.P. does not smoke,
eat chocolate, nor drink alcohol or caffeinated beverages. He
was advised at the onset of his cetyl myristoleate dosage to
avoid sugar. He is also taking Glucosaplex (a mix of glucosamines)
and Lyprinol (fatty acid extract of green lipped mussel) as an
additional natural anti-inflammatory agent.
First Page  Next Page
CMO or Cetyl Myristoleate
for Arthritis Pain and Arthritic Conditions.
Ultimate CM Plus
|
A target-specific exclusive formula,
Ultimate
